Lucid Diagnostics Inc.LUCDNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +49.68% | +15.10% | -17.28% | +19.16% | +103227.65% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +20.33% | +38.20% | +52.83% | +105.32% | +114.75% |
| Weighted Average Shares Diluted Growth | +20.33% | +38.20% | +52.83% | +105.32% | +114.75% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +85.71% | +800.00% | +24.49% | +133.13% | +1310.26% |
| Inventory Growth | +242.63% | +22.66% | +18.05% | +43.63% | +31.49% |
| Asset Growth | -32.02% | +12.63% | +2.33% | +13.36% | +135.41% |
| Book Value per Share Growth | +106.07% | +0.00% | +0.00% | -76.04% | +89.82% |
| Debt Growth | -18.75% | +39.32% | +148.77% | +93.52% | +86.25% |
| R&D Expense Growth | +3.16% | -24.24% | -4.86% | -8.53% | +76250.54% |
| SG&A Expenses Growth | +15.37% | +14.57% | +23.80% | +105926.22% | +105053.54% |